Quantcast

Latest immunotherapies Stories

2015-04-22 12:36:56

MAINZ, Germany, April 22, 2015 /PRNewswire/ -- Potential for truly personalized treatment of any cancer BioNTech AG [http://www.biontech.de

2015-03-27 08:27:09

MARLBOROUGH, Mass., March 27, 2015 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive license

2015-03-16 08:32:13

NantCell To Acquire Exclusive Rights to Antibodies Including CAR-TNK(TM) Products and the Checkpoint Inhibitors PD-1 and PD-L1 SAN DIEGO, Mar.

2015-03-11 08:29:19

LAKE FOREST, Calif., March 11, 2015 /PRNewswire/ -- Cryoport, Inc.

2015-02-17 08:35:25

ALBUQUERQUE, N.M., Feb. 17, 2015 /PRNewswire/ -- Agilvax, Inc.

2015-01-29 08:32:50

Dr. Gelder's Accomplishments Include Successful Development of Cancer Therapies at Pfizer, Wyeth and Bayer PLYMOUTH MEETING, Pa., Jan.

2015-01-16 12:23:50

Initiation of Registrational Studies Planned for This Year MORRISTOWN, N.J., Jan.

2015-01-06 08:32:02

Lead Immunotherapy Product Candidate GEN-1 to Enter Dose Escalating Clinical Study in the Second Half of 2015 LAWRENCEVILLE, N.J., Jan.

2015-01-05 12:23:52

ORLANDO, Fla., Jan. 5, 2015 /PRNewswire/ -- Immune Therapeutics Inc.


Word of the Day
dipsas
  • A serpent whose bite was fabled to produce intense thirst.
The word 'dipsas' comes from a Greek word meaning 'thirst'.